EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.4.1.65 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.4.1.65 | PC-3 cell | FT3, FT6, and FT7 | Homo sapiens | - |
2.4.1.65 | prostate | FT4 and FT9 | Homo sapiens | - |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.4.1.65 | alpha-1,3 fucosyltransferase | - |
Homo sapiens |
2.4.1.65 | FT3 | - |
Homo sapiens |
2.4.1.65 | FT6 | - |
Homo sapiens |
2.4.1.65 | FT7 | - |
Homo sapiens |
EC Number | Organism | Comment | Expression |
---|---|---|---|
2.4.1.65 | Homo sapiens | FT4 expression is 3- to 15fold lower in metastatic specimens | down |
2.4.1.65 | Homo sapiens | FT3, FT6, and FT7 are markedly elevated in bone- and liver-metastatic prostate cancer and dictate synthesis of sialyl Lewis X and endothelial selectin ligands on metastatic prostate cancer cells | up |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.4.1.65 | physiological function | alpha-1,3 fucosyltransferases can enhance metastatic efficiency of prostate cancer by triggering an endothelial selectin-dependent trafficking mechanism. Upregulated FT3, FT6, or FT7 expression induces robust prostate cancer PC-3 cell adhesion to bone marrow endothelium and to inflamed postcapillary venules in an endothelial selectin-dependent manner. FT3, FT6, and FT7 induce sialyl Lewis X expression on metastatic prostate cancer PC-3 cells. Elevated FT7 expression promotes PC-3 cell trafficking to and retention in bone marrow through an endothelial selectin dependent event | Homo sapiens |